Zebrafish live imaging: a strong weapon in anticancer drug discovery and development

被引:2
作者
Zhan, Tiancheng [1 ,2 ]
Song, Wanqian [1 ,2 ]
Jing, Guo [1 ,2 ]
Yuan, Yongkang [1 ]
Kang, Ning [1 ]
Zhang, Qiang [1 ]
机构
[1] Tianjin Univ Tradit Chinese Med, Sch Med Technol, 10 Poyanghu Rd, Tianjin 301617, Peoples R China
[2] Tianjin Univ Tradit Chinese Med, Sch Integrat Med, Tianjin, Peoples R China
基金
中国国家自然科学基金;
关键词
Cancer; Zebrafish; Live imaging; Drug screening; ADULT ZEBRAFISH; TUMOR-GROWTH; HUMAN CANCER; CELL; MODEL; TOXICITY; ANGIOGENESIS; METASTASIS; INHIBITOR; XENOGRAFT;
D O I
10.1007/s12094-024-03406-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Developing anticancer drugs is a complex and time-consuming process. The inability of current laboratory models to reflect important aspects of the tumor in vivo limits anticancer medication research. Zebrafish is a rapid, semi-automated in vivo screening platform that enables the use of non-invasive imaging methods to monitor morphology, survival, developmental status, response to drugs, locomotion, or other behaviors. Zebrafish models are widely used in drug discovery and development for anticancer drugs, especially in conjunction with live imaging techniques. Herein, we concentrated on the use of zebrafish live imaging in anticancer therapeutic research, including drug screening, efficacy assessment, toxicity assessment, and mechanism studies. Zebrafish live imaging techniques have been used in numerous studies, but this is the first time that these techniques have been comprehensively summarized and compared side by side. Finally, we discuss the hypothesis of Zebrafish Composite Model, which may provide future directions for zebrafish imaging in the field of cancer research.
引用
收藏
页码:1807 / 1835
页数:29
相关论文
共 50 条
  • [31] Role of plants in anticancer drug discovery
    Khazir, Jabeena
    Mir, Bilal Ahmad
    Pilcher, Lynne
    Riley, Darren L.
    PHYTOCHEMISTRY LETTERS, 2014, 7 : 173 - 181
  • [32] Thiazole in the targeted anticancer drug discovery
    Ayati, Adileh
    Emami, Saeed
    Moghimi, Setareh
    Foroumadi, Alireza
    FUTURE MEDICINAL CHEMISTRY, 2019, 11 (15) : 1929 - 1952
  • [33] Automated analysis of zebrafish images for phenotypic changes in drug discovery
    Chen, Shiye
    Zhu, Yongxu
    Xia, Weimina
    Xia, Shunren
    Xu, Xiaoyin
    JOURNAL OF NEUROSCIENCE METHODS, 2011, 200 (02) : 229 - 236
  • [34] Streamlining drug discovery assays for cardiovascular disease using zebrafish
    Pott, Alexander
    Rottbauer, Wolfgang
    Just, Steffen
    EXPERT OPINION ON DRUG DISCOVERY, 2020, 15 (01) : 27 - 37
  • [35] Research and Development of Combinatorial Bioengineering Using Zebrafish and Its Application on Drug Discovery
    Tamaru, Yutaka
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2009, 129 (11): : 1285 - 1293
  • [36] Overview on Anticancer Drug Design and Development
    Olgen, Sureyya
    CURRENT MEDICINAL CHEMISTRY, 2018, 25 (15) : 1704 - 1719
  • [37] Live imaging the foreign body response in zebrafish reveals how dampening inflammation reduces fibrosis
    Gurevich, David B.
    French, Kathryn E.
    Collin, John D.
    Cross, Stephen J.
    Martin, Paul
    JOURNAL OF CELL SCIENCE, 2020, 133 (05)
  • [38] Computational Approaches Towards Kinases as Attractive Targets for Anticancer Drug Discovery and Development
    Hameed, Rabia
    Khan, Afsar
    Khan, Sehroon
    Perveen, Shagufta
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2019, 19 (05) : 592 - 598
  • [39] Identification of a novel turn-on albumin binding small-molecule bioprobe in live zebrafish and its potential application in drug discovery
    Chun, Hang-Suk
    Han, Seo-Jung
    Shin, Dae-Seop
    Pagire, Haushabhau S.
    Pagire, Suvarna H.
    Lee, Gwi Bin
    Chae, Chong Hak
    Pak, Boryeong
    Jin, Suk-Won
    Chang, Young-Tae
    Park, Seung Bum
    Ahn, Jin Hee
    Bae, Myung Ae
    DYES AND PIGMENTS, 2019, 171
  • [40] Spheroids to organoids: Solid cancer models for anticancer drug discovery
    Alzeeb, George
    Corcos, Laurent
    Le Jossic-Corcos, Catherine
    BULLETIN DU CANCER, 2022, 109 (01) : 49 - 57